Oral Clinical Nutrition Market Size To Hit USD 16.73 Billion By 2032
Shivani Mhatre
???????????????????? | ?????????????????????????????? | ?????????????? ?????????????? & ???????????????? | ?????????????????????? ?????? ?????????????? | ???????? ????????????????
The global oral clinical nutrition market size was exhibited at USD 15.9 billion in 2022 and is projected to hit around USD 16.73 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2023 to 2032.
Full Report is Ready | Download Free Sample Copy with TOC@ https://www.novaoneadvisor.com/report/sample/7873
Key Pointers:
The rising prevalence of malnutrition among the adult population and the increase in the instances of obesity, rising chronic diseases such as cancer, diabetes are the major factors boosting the market growth. Oral clinical nutrition includes vitamins, proteins, and carbohydrates in powder, liquid, and semi-solid forms for oral consumption. The key market players manufacturing oral clinical nutrition products are advancing them with new flavors to enhance the taste and thereby, capture a larger customer base. This enhances the sale of oral nutritional products, which spurs the market demand.
The rising prevalence of cancer cases has led to increasing demand for nutritious food. This is due to the side effects of cancer treatment that lead to the loss of appetite, and malnutrition issues among the adult population such as loss of essential body nutrition proteins and vitamins. For instance, in an article published by the National Cancer Institute, Columbia, 2018, cancer cases will increase and reach 23.6 million by 2030. This will drive the global oral clinical nutrition market. Researchers and scientists are developing approaches to formulate nutritional products to improve nutrition deficiency and quality of life for cancer patients.
An unhealthy lifestyle leads to an increasing burden of health issues such as lack of nutrition, obesity, poor immunity leading to the rise of chronic, neurological and autoimmune diseases. In the market, key players have involved themselves in strategic initiatives involving collaboration, mergers, agreements, and acquisitions to expand the nutrition portfolio. This will propel the global market. For instance, in May 2022, Nestle Health Science agreed to acquire Puravida to expand the NHSc portfolio of nutrition segment in Brazil. The nutrition portfolio will include minerals, herbals, and vitamins supplements, nutritional beverages using plant-based foods. Eventually, this is likely to enhance the nutritional content and quality of the supplements.
Moreover, the market leaders and innovators are involved in novel product launch to enhance productivity, durability, quality, and improve the nutritional value of the food products. Along with the nutritional value, the manufacturers of clinical nutrition products are working to enhance and improve the taste of the products by incorporating different flavors. Due to this, there is more demand for oral clinical nutrition products which drives the global market. For instance, in March 2021, Kate Farms launched two products covering Medi-Cal insurance for children and adults. The products, Kate Farms Standard 1.4 Vanilla and Plain, and Kate Farms Pediatric Peptide Vanilla Flavor 1.0 are indicated to treat nutrient deficiency in patient with chronic diseases such as allergies, malnutrition in adults, cancer, and gastrointestinal disorders. Such novel product inventions are expected to drive industry growth.
The outbreak of COVID-19 had a significant impact on the oral clinical nutrition market. The viral infection led to a decrease in the immunity in the patient. Moreover, the conditions such as hypertension, obesity and diabetes were also some of the major risk factors resulting in poor clinical outcomes for hospitalized patients due to SARS-CoV-2 infection. As per the clinical studies, the population over 50-65 age was more prone to lower immunity, poor nutrition and condition such as sarcopenia. There is a rise in demand for oral clinical nutrition supplements to enhance the body immunity driving the overall market. Various public and private entities involved in R&D and research have started developing oral clinical nutrition solutions for COVID-19-infected patients to cater to the issues of nutritional deficiency. Moreover, there is a rise in the number of clinical studies to understand the potential benefits and effects of Vitamin D, and Vitamin C nutritional supplements for the treatment of patients with COVID-19 infection, which is further expected to drive the global market.
Some of the prominent players in the Oral Clinical Nutrition Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Oral Clinical Nutrition market.
领英推荐
By Stage?
By Indication?
By Sales Channel?
By Region
Full Report is Ready | Purchase This Premium Report Now@ https://www.novaoneadvisor.com/report/checkout/7873
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.